RAD 001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RAD 001, covering 2012-12-24 to 2016-06-21. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium [Phase 2]